ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ACTU on Nasdaq
Shares outstanding
23,165,208
Price per share
$6.56
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
12,026,097
Total reported value
$80,455,749
% of total 13F portfolios
0.01%
Share change
+808,239
Value change
+$5,410,880
Number of holders
42
Price from insider filings
$6.56
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOS Fund I, LP 50% -2.9% $112,734,207 +$1,733,259 10,267,232 +1.6% AARON G.L. FLETCHER 27 Jun 2025
Voss Capital, LP 5.3% $8,471,516 1,227,756 Voss Capital, LP 15 Dec 2025

As of 30 Sep 2025, 42 institutional investors reported holding 12,026,097 shares of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU). This represents 52% of the company’s total 23,165,208 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BIOS Capital Management, LP 43% 10,049,996 +0.85% 76% $67,234,473
Voss Capital, LP 3.9% 896,278 +213% 0.34% $5,996,100
VANGUARD GROUP INC 1.4% 316,010 +19% 0% $2,114,107
BlackRock, Inc. 1.2% 282,074 +44% 0% $1,887,075
GEODE CAPITAL MANAGEMENT, LLC 0.63% 145,412 +23% 0% $972,805
NORTHERN TRUST CORP 0.37% 85,454 -0.28% 0% $571,687
STATE STREET CORP 0.22% 49,895 +59% 0% $333,798
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 0.08% 19,301 +4.2% 0% $129,124
Gleason Group, Inc. 0.08% 19,028 0% 0.01% $127,297
SFMG, LLC 0.07% 17,000 +17% 0.01% $113,730
LPL Financial LLC 0.07% 16,215 -13% 0% $108,478
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.06% 14,765 0% 0% $98,778
WELLS FARGO & COMPANY/MN 0.06% 13,542 +5.8% 0% $90,596
ROYAL BANK OF CANADA 0.06% 12,891 +892% 0% $86,000
Freestone Capital Holdings, LLC 0.04% 10,000 0% 0% $66,900
UBS Group AG 0.04% 8,927 +280% 0% $59,722
BARCLAYS PLC 0.04% 8,865 -76% 0% $59,307
RHUMBLINE ADVISERS 0.04% 8,768 -3.5% 0% $58,653
MORGAN STANLEY 0.03% 7,626 -1.5% 0% $51,018
NORTHWESTERN UNIVERSITY 0.03% 6,488 -77% 0.08% $43,405
Global Retirement Partners, LLC 0.03% 6,250 0% 0% $41,813
NEW YORK STATE COMMON RETIREMENT FUND 0.03% 6,200 -64% 0% $41,478
Wealthspire Advisors, LLC 0.02% 5,000 0% $33,450
BANK OF AMERICA CORP /DE/ 0.02% 4,872 -68% 0% $32,594
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.01% 2,683 -16% 0% $17,949

Institutional Holders of ACTUATE THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ACTU) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 19,029 $116,458 +$7 $6.56 2
2025 Q3 12,026,097 $80,455,749 +$5,410,880 $6.69 42
2025 Q2 11,217,203 $68,541,901 +$4,868,272 $6.11 38
2025 Q1 10,401,592 $70,445,498 +$1,934,199 $6.77 25
2024 Q4 10,116,136 $80,524,037 -$1,087,916 $7.96 19
2024 Q3 382,167 $2,847,155 +$2,847,155 $7.45 10